BIND Therapeutics: Oppenheimer & Co. Healthcare Conference (BIND Therapeutics) - Dec 13, 2014 - Anticipated data readout from P2 trial for KRAS NSCLC in Q1 2016; Anticipated data readout from P2 trial for squamous NSCLC in Q1 2016; Anticipated data readout from P2 trial for 1st-line chemotherapy naive mCRPC in early Q1 2015; Anticipated stage 1 data readout from P2 trial for bladder, cervical, cholangio and head and neck cancer in H1 2016; Anticipated stage 2 data readout from P2 trial for bladder, cervical, cholangio and head and neck cancer in H2 2016
Anticipated P2 data • Oncology
|